J&J's DePuy acquisition
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson files a notification and report form under the Hart-Scott-Rodino Act with respect to its $3.5 bil. cash tender offer for the Roche orthopedic products unit ("The Gray Sheet" July 27, p. 7). The HSR waiting period expires on Aug. 19. Separately, DePuy reports a 7% increase in revenues during the second quarter of 1998 to $219.2 mil. Net income rose 8.5% to $35.3 mil., not including a one-time $131.5 mil. charge associated with the acquisition of AcroMed on June 3